Inhibition of platelet aggregation after subcutaneous administration of a single-dose of selatogrel, a novel P2Y12 antagonist, in acute myocardial infarction: a randomised open-label phase 2 study
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
University Hospitals (UZ) Leuven, Leuven (Belgium)
3 More presentations in this session
Professor G. Heusch (Essen, DE)
Doctor A. Abbate (Charlottesville, US)
Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
